To evaluate the clinical value of iodized oil marking-guided percutaneous biopsy with hepatic arterial catheterization for hepatic space-occupying lesions (HSOLs), highlighting its significance in improving diagnostic accuracy.
Key Findings:
Successful sampling was achieved in all cases, with sufficient specimens for pathological diagnosis, achieving a diagnostic accuracy of X%.
The diagnostic accuracy was high, with a significant number of neoplastic lesions identified, specifically Y% of cases.
Complications were minimal and manageable, with no major adverse events reported, indicating a safety profile comparable to existing methods.
Interpretation:
Iodized oil marking combined with hepatic artery catheterization enhances the safety and efficacy of percutaneous biopsy for HSOLs, particularly in challenging cases, potentially changing clinical practice.
Limitations:
Retrospective design may introduce selection bias and other biases inherent in non-randomized studies.
Limited sample size may affect the generalizability of findings, suggesting the need for larger prospective studies.
Conclusion:
Iodized oil-assisted biopsy with hepatic artery catheter protection is a promising technique for diagnosing HSOLs, offering improved safety and diagnostic yield, which could significantly impact clinical decision-making.
